Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney disease

Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life

(2012) Wendy E. Hoy et al.   KIDNEY INTERNATIONAL

Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India

(2012) Thangarajan Anand et al.   Annals of Clinical Microbiology and Antimicrobials

Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS)

(2011) Yumi Shimomura et al.   BMC GENOMICS

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

(2011) William G. Couser et al.   KIDNEY INTERNATIONAL

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?

(2009) Pierre R Smeesters et al.   Expert Review of Vaccines

Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children

(2009) P. V. Bramhachari et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Comparative analysis of emm type pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor

(2008) Vivek Sagar et al.   BMC MICROBIOLOGY

Seroreactivity against Streptococcal DRS (Distantly Related to SIC) Protein Is a Predictor for End-Stage Renal Failure

(2008) V. A. F. Boon et al.   Clinical and Vaccine Immunology